Mucormycosis- A Catastrophic Challenge in COVID-19 Pandemic
Abstract
Recently amidst the second wave of COVID-19, various opportunistic infections were observed globally. Amongst all, COVID-19 associated mucormycosis (CAM) was the most fatal invasive fungal infection,
which was declared as an epidemic and notifiable disease in many states in India. it had caused a huge increase in mucormycosis cases which was initially considered a rare disease. As per the latest scenario, India has seen a total of 40,845 cases of black fungus until 28 June, of which 31,344 cases were rhino-cerebral, and the death toll from the infections stands at 3,129.
This article aims to provide a succinct list of warning signs to suspect Rhino-Orbital-Cerebral Mucormycosis (ROCM), to detect the disease at an early stage, use a proper diagnostic test available and follow an evidence-based management strategy and also outline various preventive measures.
How to cite this article:
Priyanka, Shakarwal S, Singh P. Mucormycosis- A Catastrophic Challenge in Covid-19 Pandemic. J Adv Res Med. 2021;8(3):13-18.
DOI: https://doi.org/10.24321/2349.7181.202114
References
Eucker J, Sezer O, Graf B, Possinger K. Mucormycosis. Mycoses. 2001;44(7):253e60. [PubMed] [Google
Scholar]
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, SarkisovaTA, Schaufele RL et al (2005) Epidemiology
and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis41:634–653. [PubMed] [Google
Scholar]
Goyal P et al (2020) Clinical characteristics of Covid19 in New York City. N Engl J Med. https://doi.org/10.1056/
nejmc2010419. [PubMed] [Google Scholar]
WHO. COVID-19 Weekly Epidemiological Update. July 26, 2021. https://www.who.int/ docs/default source/
coronaviruses/ situation reports/ 20210525_weekly_epi_update_41. (Accessed July 26, 2021).
Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 9th edition 2020. [Google Scholar]6. Longo, Fauci, Kasper, Hauser, Jameson, Loscalzo. Harrison’s Principle of Internal Medicine.20th
Edition.2018: p1537-1541. [PubMed] [Google Scholar]
Guan W-J, Ni Z-Y, Hu Y, Liang W-h, Ou C-Q, He J-X et al (2020) Clinical characteristics of 2019 novel coronavirus
infection in China. MedRxiv
Koparal M, Kurt E, Altuntas EE, Dogan F (2021) Assessment of mucociliary clearance as an indicator
of nasal function in patients with COVID-19: a crosssectional study. Eur Arch Otorhinolaryngology
(6):1863–1868. [PubMed] [Google Scholar]
Çeçen A, Bayraktar C, Özgür A, Akgül G, Günal O, ¨Evaluation of nasal mucociliary clearance time in
COVID-19 patients. J Craniofac Surg. 2021 Nov-Dec 01;32(8):e702-e705. [PubMed] [Google Scholar]
Indian Council of Medical Research [Internet]. Evidence based advisory in the time of COVID-19 (screening,
diagnosis & management of mucormycosis). May 9, 2021. https://www.icmr.gov.in/pdf/covid/techdoc/
Mucormycosis_ADVISORY_FROM_ICMR_In_COVID-19.
Branscomb R. An overview of mucormycosis. Lab Med.2002 (June): 33(6);453-5. [Google Scholar]
https://dghs.MoHF.gov.in/Guideline for management of Mucormycosis in Covid – 19 patients.17th may 2021.
Dadwal SS, Kontoyiannis DP. Recent advances in the molecular diagnosis of mucormycosis. Expert Rev Mol
Diagn. 2018 Oct;18(10):845-854. [PubMed] [Google Scholar]
Honavar SG. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral
Mucormycosis in the Setting of COVID-19. Indian J Ophthalmol 2021; 69(6):1361-5. [PubMed] [Google
Scholar]
Skied A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: An update. J Fungi
(Basel) 2020;6:265. [PubMed] [Google Scholar]
John TM, Jacob CN. Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi. 2021; 7:298. [PubMed] [Google Scholar]
Copyright (c) 2021 Priyanka, Shalini Shakarwal, Pratap Singh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
